======= C17orf96 =======
== Gene Information ==
* **Official Symbol**: EPOP
* **Official Name**: elongin BC and polycomb repressive complex 2 associated protein
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=100170841|100170841]]
* **UniProt**: [[https://www.uniprot.org/uniprot/A6NHQ4|A6NHQ4]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=C17orf96&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C17orf96|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/617795|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Scaffold protein that serves as a bridging partner between the PRC2/EED-EZH2 complex and the elongin BC complex: required to fine-tune the transcriptional status of Polycomb group (PcG) target genes in embryonic stem cells (ESCs). Plays a key role in genomic regions that display both active and repressive chromatin properties in pluripotent stem cells by sustaining low level expression at PcG target genes: acts by recruiting the elongin BC complex, thereby restricting excessive activity of the PRC2/EED-EZH2 complex. Interaction with USP7 promotes deubiquitination of H2B at promoter sites. Acts as a regulator of neuronal differentiation. {ECO:0000250|UniProtKB:Q7TNS8}.
No Pfam Domain information is available for this gene.
|histone H2B conserved C-terminal lysine deubiquitination|
|elongin complex|
|ESC/E(Z) complex|
|histone deubiquitination|
|neuron fate commitment|
|chromosome|
|stem cell differentiation|
|cell fate commitment|
|protein deubiquitination|
|protein modification by small protein removal|
|histone modification|
|covalent chromatin modification|
|chromatin binding|
|chromatin organization|
|protein modification by small protein conjugation or removal|
|neuron differentiation|
|chromosome organization|
|proteolysis|
|generation of neurons|
|neurogenesis|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|-1.86|
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|1.92|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 11/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|1/13|
|fibroblast|0/1|
|gastric|2/16|
|kidney|0/21|
|liver|0/20|
|lung|2/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|1/22|
|urinary tract|2/29|
|uterus|1/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 11732
* **Expression level (log2 read counts)**: 4.71
{{:chemogenomics:nalm6 dist.png?nolink |}}